CLINICAL_TRIALS
trial_result
· 2022-06-27
Clinical Trial Update: Intravenous Iron Carboxymaltose, Isomaltoside and Oral Iron Sulphate for Postpartum Anemia [Phase 3]
Summary
Phase 3 trial results comparing intravenous iron carboxymaltose, isomaltoside, and oral iron sulfate for postpartum anemia have been completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University Medical Centre Ljubljana | Conditions: Postpartum Anemia Nos, Iron-deficiency | Phase 3 | Status: COMPLETED